Safety and Efficacy Study of TPI-287 in Neuroblastoma and Medulloblastoma
NCT01483820
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
TERMINATED
Status
8
Enrollment
OTHER
Sponsor class
Stopped
Lack of enrollment
Conditions
Neuroblastoma
Medulloblastoma
Interventions
DRUG:
TPI 287
Sponsor
Giselle Sholler
Collaborators
[object Object]